Search

everythinglearnresearchcommunity

for

Search:↓

Six new genes linked to early hair loss were found, which also surprisingly connect to Parkinson's disease and lower fertility.

Six new genes linked to early hair loss were found, which also surprisingly connect to Parkinson's disease and lower fertility.

Six new risk spots for early hair loss were found, which also link to Parkinson's disease and lower fertility. Two genes, FOXA2 and HDAC4, could be new treatment targets. Hair loss might also be connected to heart disease, metabolic syndrome, and prostate cancer.

Androgenetic alopecia, or hair loss, is caused by genetic factors and hormones, with different mechanisms in men and women, and can be linked to insulin resistance and polycystic ovary syndrome.

Society's pressure to have children later in life favors genes that increase the risk of early baldness in male offspring.

Hair loss can be treated with common methods like minoxidil and finasteride, but new potential treatments include growth factors, cytokines, and platelet-rich plasma injections.

New methods can diagnose hair loss by examining the scalp and can treat it with a mix of oral and topical medications, along with cosmetic procedures like hair transplants.

Genetic differences in hair loss can help improve diagnosis and treatment.

Muscles can make their own androgens, which may help muscle growth.

New treatments for male hypogonadism are effective and should be personalized.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

Acupuncture may improve reproductive and metabolic functions in PCOS without negative side effects, but more research is needed to confirm its effectiveness.

Bicalutamide may help treat female pattern hair loss.

Testosterone replacement therapy helps manage deficiency and has various methods, but requires careful monitoring to avoid side effects.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Spironolactone may help enlarge a small breast linked to Becker's nevus.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Bolandiol, a synthetic steroid, builds muscle and bone without greatly affecting sex glands, and works differently from other hormones.

Estrogens are key for bone growth spurts in both boys and girls and affect growth into adulthood.

Bisphenol-A (BPA) increases connections between brain cells and boosts their activity, but it blocks the effects of a male hormone on brain cell plasticity.

RE-ORGA, a Korean herb extract, may help prevent hair loss.

Personalized treatments for hair loss are becoming more effective by using genetic information.

Antibody treatments show promise for hair loss but need more research.

People with androgenetic alopecia may have a higher risk of severe COVID-19.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

The conclusion suggests a new treatment for infantile hemangiomas and a potential target for hair loss treatment.

Mutations in the AR gene cause hair thinning and loss.